Heparin rebound. Studies in patients and volunteers. - Suppr | 超能文献

Heparin rebound. Studies in patients and volunteers.

作者信息

Ellison N, Beatty C P, Blake D R, Wurzel H A, MacVaugh H

出版信息

J Thorac Cardiovasc Surg. 1974 May;67(5):723-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Heparin rebound. Studies in patients and volunteers.

J Thorac Cardiovasc Surg. 1974 May;67(5):723-9.

2

Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding.

J Thorac Cardiovasc Surg. 1979 Jul;78(1):95-102.

3

[Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].

Anesteziol Reanimatol. 1981 Sep-Oct(5):52-6.

4

[Present state of heparin therapy].

Presse Med (1893). 1969 Mar 26;77(15):553-6.

5

[Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].

Fukuoka Igaku Zasshi. 1974 Nov;65(11):878-88.

6

Heparin rebound in open heart surgery.心脏直视手术中的肝素反跳

Surg Gynecol Obstet. 1967 Feb;124(2):337-46.

7

[Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].

Arq Bras Cardiol. 1989 Mar;52(3):137-9.

8

Heparin dosage in extracorporeal circulation and its neutralization.

Thromb Diath Haemorrh. 1975 Feb 28;33(1):102-4.

9

Evaluation of the activated clotting time to control heparin andprotamine dosage in open-heart surgery.

J Thorac Cardiovasc Surg. 1978 May;75(5):790-2.

10

[Hemorrhages during cardiac surgery with extracorporeal circulation].[体外循环心脏手术期间的出血情况]

Ann Chir Thorac Cardiovasc. 1967 Jul;6(3):323-7.

引用本文的文献

1

Heparin rebound in patients undergoing off-pump coronary artery bypass grafting surgery: a single-center retrospective study.非体外循环冠状动脉搭桥手术患者的肝素反跳：一项单中心回顾性研究

J Cardiothorac Surg. 2025 Jan 4;20(1):18. doi: 10.1186/s13019-024-03267-9.

2

Intraaortic administration of protamine: Method for heparin neutralization after cardiopulmonary bypass.鱼精蛋白主动脉内给药：体外循环后肝素中和的方法。

Cardiovasc Dis. 1981 Mar;8(1):23-28.

3

The hemostatic defect of cardiopulmonary bypass.体外循环的止血缺陷。

J Thromb Thrombolysis. 2003 Dec;16(3):129-47. doi: 10.1023/B:THRO.0000024051.12177.e9.

4

Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model.低分子量鱼精蛋白作为无毒肝素/低分子量肝素解毒剂（III）：使用犬模型进行疗效和毒性的初步体内评估。

AAPS PharmSci. 2001;3(3):E19. doi: 10.1208/ps030319.